Gene · 8740
Papers1,880
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,880
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gut microbiota, circulating inflammatory markers and metabolites, and carotid artery atherosclerosis in HIV infection. | Microbiome | 2023 | 37237391 | PubTator, text mining | PubMed |
| Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors. | J Immunother Cancer | 2023 | 37230538 | PubTator, text mining | PubMed |
| Reciprocal costimulatory molecules control the activation of mucosal type 3 innate lymphoid cells during engagement with B cells. | Cell Mol Immunol | 2023 | 37225838 | PubTator, text mining | PubMed |
| Identification and validation of oxeiptosis-associated lncRNAs and prognosis-related signature genes to predict the immune status in uterine corpus endometrial carcinoma. | Aging (Albany NY) | 2023 | 37211398 | PubTator, text mining | PubMed |
| Single-cell atlas of the human neonatal small intestine affected by necrotizing enterocolitis. | PLoS Biol | 2023 | 37205711 | PubTator, text mining | PubMed |
| Comprehensive transcriptomic analyses identify KDM genes-related subtypes with different TME infiltrates in gastric cancer. | BMC Cancer | 2023 | 37202737 | PubTator, text mining | PubMed |
| PI16+ reticular cells in human palatine tonsils govern T cell activity in distinct subepithelial niches. | Nat Immunol | 2023 | 37202490 | PubTator, text mining | PubMed |
| Characterisation of X chromosome status of human extended pluripotent stem cells. | Cell Prolif | 2023 | 37199042 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Exosomes Modulate Angiogenesis in Gastric Cancer. | Biomedicines | 2023 | 37189649 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Expression, Prognostic Value, and Immune Infiltration Activities of GABRD in Colon Adenocarcinoma. | Mediators Inflamm | 2023 | 37181811 | PubTator, text mining | PubMed |
| Systemic Analyses of Cuproptosis-Related lncRNAs in Pancreatic Adenocarcinoma, with a Focus on the Molecular Mechanism of LINC00853. | Int J Mol Sci | 2023 | 37175629 | PubTator, text mining | PubMed |
| Shining a LIGHT on myeloid cell targeted immunotherapy. | Eur J Cancer | 2023 | 37167762 | PubTator, text mining | PubMed |
| A tessellated lymphoid network provides whole-body T cell surveillance in zebrafish. | Proc Natl Acad Sci U S A | 2023 | 37155881 | PubTator, text mining | PubMed |
| Exploration of spatial heterogeneity of tumor microenvironment in nasopharyngeal carcinoma via transcriptional digital spatial profiling. | Int J Biol Sci | 2023 | 37151882 | PubTator, text mining | PubMed |
| A human model of asthma exacerbation reveals transcriptional programs and cell circuits specific to allergic asthma. | Sci Immunol | 2023 | 37146132 | PubTator, text mining | PubMed |
| A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer. | Medicine (Baltimore) | 2023 | 37145007 | PubTator, text mining | PubMed |
| Innate immunity and nonalcoholic fatty liver disease. | Ann Gastroenterol | 2023 | 37144011 | PubTator, text mining | PubMed |
| Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer. | Front Endocrinol (Lausanne) | 2023 | 37143720 | PubTator, text mining | PubMed |
| A novel signature based on cancer-associated fibroblast genes to predict prognosis, immune feature, and therapeutic response in breast cancer. | Aging (Albany NY) | 2023 | 37142271 | PubTator, text mining | PubMed |
| Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease. | J Pers Med | 2023 | 37109050 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8740/papers?page=18